Calin from Hirudo medicinalis, an inhibitor of platelet adhesion to collagen, prevents platelet-rich thrombosis in hamsters.
Interaction between exposed collagen and platelets and/or von Willebrand factor is believed to be one of the initiating events for thrombus formation at sites of damaged endothelium. Interference with this mechanism may provide an anti-thrombotic potential. Calin, a product from the saliva of the leech Hirudo medicinalis, was tested in vitro and for its in vivo activity in a thrombosis model in hamsters. Calin specifically and dose dependently (IC50:6.5 to 13 micrograms/mL) inhibited human platelet aggregation induced by collagen. In addition, specific platelet adhesion onto microtiter wells coated with collagen and detected with a monoclonal antiglycoprotein IIb/IIIa antibody-conjugated with horseradish peroxidase, could be completely prevented with Calin (IC50:22 micrograms/mL). A dose-response curve was constructed in groups of six hamsters in whom a standardized trauma was induced on the femoral vein. Thrombus formation was followed continuously using video recording and processing of the image obtained upon transillumination of the vessel. Intravenous Calin dose-dependently inhibited platelet-rich thrombus formation in this model with an ED50 of 0.07 mg/kg and complete inhibition with 0.2 mg/kg. No effects were seen on coagulation tests or bleeding times, whereas ex vivo aggregation induced by collagen was inhibited dose dependently. Local application of leech saliva, Calin, hirudin, or the combination of the latter two into the bleeding time wound of hamsters resulted in a mild prolongation of the bleeding time (twofold to threefold). A similar experiment in baboons did not cause any prolongation of the bleeding time. This is in sharp contrast with the long-lasting bleeding after a leech bite itself in both species. Calin from the leech Hirudo medicinalis is able, by binding to collagen, to effectively interfere with platelet-collagen interaction, which results in an antithrombotic effect observed in a platelet-rich thrombosis model in hamsters.
Center for Molecular and Vascular Biology, University of Leuven, Belgium.
H
H
Deckmyn
J M
JM
Stassen
I
I
Vreys
E
E
Van Houtte
R T
RT
Sawyer
J
J
Vermylen
D000818:Animals; D001733:Bites and Stings; D003094:Collagen / Q000187:drug effects; D006224:Cricetinae; D004305:Dose-Response Relationship, Drug; D005268:Femoral Vein; D006629:Hirudins / Q000494:pharmacology; D006801:Humans; D007447:Invertebrate Hormones / Q000494:pharmacology* / Q000627:therapeutic use; D007865:Leeches; D008297:Male; D008647:Mesocricetus; D010215:Papio; D010973:Platelet Adhesiveness / Q000187:drug effects*; D010974:Platelet Aggregation / Q000187:drug effects*; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology*; D012463:Saliva / Q000502:physiology; D012471:Salivary Proteins and Peptides / Q000494:pharmacology* / Q000627:therapeutic use; D013927:Thrombosis / Q000517:prevention & control*
D006629:Hirudins; D007447:Invertebrate Hormones; D010975:Platelet Aggregation Inhibitors; D012471:Salivary Proteins and Peptides; C072490:calin; D003094:Collagen